Pharma Firm Inotiv Confirms Data Breach Following Ransomware Attack
\n \t
\n
<\/BR>
\n
\n \t
\n
<\/BR><\/p>\n
A leading contract research organization specializing in pharmaceutical drug discovery and development services disclosed a significant data breach stemming from a ransomware attack<\/a> that occurred in early August 2025.<\/p>\n The Inotiv company announced the cybersecurity incident in its fiscal 2025 financial results disclosure. Revealing that threat actors gained unauthorized<\/a> access to critical systems between August 5 and August 8.<\/p>\n The West Lafayette, Indiana-based firm discovered the breach on August 8, 2025, and immediately initiated incident response procedures.<\/p>\n Inotiv restored availability and access to affected networks and systems, followed by a comprehensive forensic investigation that has now concluded.<\/p>\n During the four-day compromise window, attackers successfully infiltrated the company\u2019s infrastructure and acquired an unspecified amount of company data. Though the exact scope and sensitivity of exfiltrated information remains unclear.<\/p>\n In regulatory filings, Inotiv stated that it is currently providing notifications regarding the cybersecurity incident in accordance with applicable legal obligations. Indicating potential state and federal disclosure requirements are in motion.<\/p>\n Inotiv acknowledged that, while it has identified the likely scope of the breach<\/a>, the full operational and financial impacts are still under evaluation.<\/p>\n Notably, Inotiv has not yet determined whether the incident is reasonably likely to have material financial consequences for the organization. The breach adds to Inotiv\u2019s existing operational challenges.<\/p>\n The pharmaceutical services provider is navigating substantial debt obligations totaling $402.1 million and recently engaged financial advisors to explore debt refinancing alternatives.<\/p>\n During fiscal 2025, the company reported revenue of $513 million but posted an operating loss of $30.9 million.<\/p>\n Inotiv\u2019s incident disclosure<\/a> comes amid broader ransomware targeting of healthcare and pharmaceutical organizations.<\/p>\n The contract research sector handles sensitive clinical data, proprietary drug development information, and regulatory documentation, making these firms attractive targets for threat actors<\/a>.<\/p>\n The company\u2019s financial guidance did not specify whether incident remediation costs would impact future earnings or were already factored into current loss projections.<\/p>\n The incident underscores the cybersecurity risks faced by pharmaceutical research organizations that manage high-value intellectual property and confidential client data throughout the drug development pipeline.<\/p>\n The post Pharma Firm Inotiv Confirms Data Breach Following Ransomware Attack<\/a> appeared first on Cyber Security News<\/a>.<\/p>\n<\/div>\nPharma Firm Inotiv Data Breach<\/strong><\/h2>\n